Literature DB >> 7790102

Role of interleukin-6 in T-cell activation during primary and secondary infection with Listeria monocytogenes.

Z Liu1, R J Simpson, C Cheers.   

Abstract

Injection of recombinant interleukin-6 (IL-6) into mice enhances recovery from infection with Listeria monocytogenes. In this study, the role of IL-6 during primary and secondary Listeria infection was further tested. Neutralization of IL-6 by polyclonal antibody exacerbated primary infection and significantly delayed gamma interferon production by cultured spleen cells. In contrast, administration of anti-IL-6 antibody at the time of secondary infection did not affect the recovery of mice from infection or gamma interferon production, showing that activated T cells are not dependent on IL-6.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790102      PMCID: PMC173376          DOI: 10.1128/iai.63.7.2790-2792.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Treatment of mice with human recombinant interleukin-2 augments resistance to the facultative intracellular pathogen Listeria monocytogenes.

Authors:  M Haak-Frendscho; K M Young; C J Czuprynski
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

2.  Role of IL-6 in activation of T cells for acquired cellular resistance to Listeria monocytogenes.

Authors:  Z Liu; R J Simpson; C Cheers
Journal:  J Immunol       Date:  1994-06-01       Impact factor: 5.422

3.  Protection of mice against the intracellular bacterium Listeria monocytogenes by recombinant immune interferon.

Authors:  A F Kiderlen; S H Kaufmann; M L Lohmann-Matthes
Journal:  Eur J Immunol       Date:  1984-10       Impact factor: 5.532

4.  Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection.

Authors:  A Nakane; T Minagawa; K Kato
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

5.  Recombinant interleukin-6 protects mice against experimental bacterial infection.

Authors:  Z Liu; R J Simpson; C Cheers
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

6.  Production of tumor necrosis factor during murine listeriosis.

Authors:  E A Havell
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

7.  Interferon-gamma production by Listeria monocytogenes-specific T cells active in cellular antibacterial immunity.

Authors:  S H Kaufmann; H Hahn; R Berger; H Kirchner
Journal:  Eur J Immunol       Date:  1983-03       Impact factor: 5.532

8.  Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection.

Authors:  N A Buchmeier; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

9.  The cellular source of interleukin-6 during Listeria infection.

Authors:  Z Liu; C Cheers
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

10.  Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.

Authors:  J Van Snick; S Cayphas; A Vink; C Uyttenhove; P G Coulie; M R Rubira; R J Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more
  3 in total

1.  Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine.

Authors:  I S Leal; B Smedegârd; P Andersen; R Appelberg
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Interleukin-6 regulates the phenotype of the immune response to a tuberculosis subunit vaccine.

Authors:  I S Leal; M Flórido; P Andersen; R Appelberg
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

3.  IFN-Gamma-Dependent and Independent Mechanisms of CD4⁺ Memory T Cell-Mediated Protection from Listeria Infection.

Authors:  Stephanie M Meek; Matthew A Williams
Journal:  Pathogens       Date:  2018-02-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.